PathoGenetix Raises $4M in First Closing of Series B Financing
August 02, 2011
PathoGenetix Raises $4M in First Closing of Series B Financing
The company, formerly called US Genomics, will use the funding to complete development of its system for identifying pathogens in complex biological samples, which is scheduled for commercial release in 2012.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- New Products: Swift Biosciences' Accel-NGS Kit; Roche/Hamilton's Automated DNA Enrichment; More
March 5, 2013 / In Sequence - People in the News: Paul Krassnoff, Jerome Rotter
February 13, 2013 / Clinical Sequencing News - ABRF to Present Sequencing Platform Performance Study Next Week
March 13, 2012 / In Sequence - Pathogenetix Targets 2012 Launch for 'Sequence Shorthand' Tech to ID Microbes
November 15, 2011 / In Sequence - PathoGenetix Raises $7.5M in Second Closing of Series B Financing
November 1, 2011 / In Sequence